These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 18283647

  • 1. FXR, a target for different diseases.
    Wang YD, Chen WD, Huang W.
    Histol Histopathol; 2008 May; 23(5):621-7. PubMed ID: 18283647
    [Abstract] [Full Text] [Related]

  • 2. FXR: a metabolic regulator and cell protector.
    Wang YD, Chen WD, Moore DD, Huang W.
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [Abstract] [Full Text] [Related]

  • 3. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B.
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [Abstract] [Full Text] [Related]

  • 4. FXR, a therapeutic target for bile acid and lipid disorders.
    Westin S, Heyman RA, Martin R.
    Mini Rev Med Chem; 2005 Aug; 5(8):719-27. PubMed ID: 16101408
    [Abstract] [Full Text] [Related]

  • 5. FXR signaling in metabolic disease.
    Zhang Y, Edwards PA.
    FEBS Lett; 2008 Jan 09; 582(1):10-8. PubMed ID: 18023284
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P, Hierro L, Jara P, Alvarez L.
    Am J Physiol Gastrointest Liver Physiol; 2009 May 09; 296(5):G1119-29. PubMed ID: 19228886
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. FXR, a multipurpose nuclear receptor.
    Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y.
    Trends Biochem Sci; 2006 Oct 09; 31(10):572-80. PubMed ID: 16908160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Müller M, Frants RR, Kasanmoentalib S, Post SM, Princen HM, Porter JG, Katan MB, Hofker MH, Moore DD.
    Mol Endocrinol; 2007 Jul 09; 21(7):1603-16. PubMed ID: 17456796
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.
    Edwards PA, Kast HR, Anisfeld AM.
    J Lipid Res; 2002 Jan 09; 43(1):2-12. PubMed ID: 11792716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.